Cancer Cell
Corrections Figure 3. p38/MK2 Inhibits Smac-Mimetic-Induced JNK1/2 and ERK1/2 Phosphorylation (original)
A
Mapk14fl/fl
B
Mapk14LC
C Mk2 P
P
P
P
P
P
49 P
P
reprobe
P P
49
reprobe
P
P
P
49
P
P
P
P
P
reprobe
49
P
P
P P
P
49
P
P
P
49
P
reprobe
reprobe
49
P P
P
P
P
reprobe GAPDH
P
reprobe
49
GAPDH
P P
reprobe actin
actin
P
49
49
reprobe 49
reprobe actin
49
actin
9
Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade Haidong Tang, Yang Wang, Lukasz K. Chlewicki, Yuan Zhang, Jingya Guo, Wei Liang, Jieyi Wang, Xiaoxiao Wang, and Yang-Xin Fu* *Correspondence:
[email protected] http://dx.doi.org/10.1016/j.ccell.2016.08.011
(Cancer Cell 29, 285–296; March 14, 2016) During the copyediting stage of the production process, an error was accidentally introduced into the manuscript that resulted in the incorrect name of a protein. In the version originally published, ‘‘tumor necrosis factor receptor superfamily member 14’’ had been removed and abbreviated as TNFSF14. The corrected sentence now reads as follows: ‘‘LIGHT is a ligand protein that can bind to two different receptors, herpesvirus entry mediator (HVEM), which is also known as tumor necrosis factor receptor superfamily member 14 (TNFRSF14) and is encoded by TNFRSF14, and lymphotoxin b receptor (LTbR), which is encoded by LTBR.’’ This mistake has now been corrected online. We apologize to our readers for this error and any confusion that it might have caused.
500 Cancer Cell 30, 499–503, September 12, 2016 ª 2016 Elsevier Inc.